Switzerland: Innovation Launchpad with Global Potential

Switzerland stands as an exceptional innovation hub despite its small population of just eight million. Mr. Nasri Nahas – CEO, Biopôle highlights that Switzerland leads globally in biotech companies and fundraising per capita, with outstanding scientific output metrics.Rather than viewing Switzerland as a traditional market, Nasri Nahas positions it as an innovation launchpad—a place where companies can validate concepts, secure Swissmedic approval, and demonstrate clinical impact before scaling internationally.

(Link to the full interview of Nasri Nahas – CEO Biopôle in Lausanne Switzerland -  below)

https://pharmaboardroom.com/interviews/nasri-nahas-ceo-biopole/